The Role of Age and Excess Body Mass Index in Progression to Type 1 Diabetes in At-Risk Adults

Christine T Ferrara, Susan M Geyer, Carmella Evans-Molina, Ingrid M Libman, Dorothy J Becker, John M Wentworth, Antoinette Moran, Stephen E Gitelman, Maria J Redondo, Type 1 Diabetes TrialNet Study Group, Christine T Ferrara, Susan M Geyer, Carmella Evans-Molina, Ingrid M Libman, Dorothy J Becker, John M Wentworth, Antoinette Moran, Stephen E Gitelman, Maria J Redondo, Type 1 Diabetes TrialNet Study Group

Abstract

Background: Given the global rise in both type 1 diabetes incidence and obesity, the role of body mass index (BMI) on type 1 diabetes pathophysiology has gained great interest. Sustained excess BMI in pediatric participants of the TrialNet Pathway to Prevention (PTP) cohort increased risk for progression to type 1 diabetes, but the effects of age and obesity in adults remain largely unknown.

Objective: To determine the effect of age and sustained obesity on the risk for type 1 diabetes in adult participants in the TrialNet PTP cohort (i.e., nondiabetic autoantibody-positive relatives of patients with type 1 diabetes).

Research design and methods: Longitudinally accumulated BMI >25 kg/m2 was calculated to generate a cumulative excess BMI (ceBMI) for each participant, with ceBMI values ≥0 kg/m2 and ≥5 kg/m2 representing sustained overweight or obese status, respectively. Recursive partitioning analysis yielded sex- and age-specific thresholds for ceBMI that confer the greatest risk for type 1 diabetes progression.

Results: In this cohort of 665 adults (age 20 to 50 years; median follow-up, 3.9 years), 49 participants developed type 1 diabetes. Age was an independent protective factor for type 1 diabetes progression (hazard ratio, 0.95; P = 0.008), with a threshold of >35 years that reduced risk for type 1 diabetes. In men age >35 years and women age <35 years, sustained obesity (ceBMI ≥5 kg/m2) increased the risk for type 1 diabetes.

Conclusions: Age is an important factor for type 1 diabetes progression in adults and influences the impact of elevated BMI, indicating an interplay of excess weight, age, and sex in adult type 1 diabetes pathophysiology.

Trial registration: ClinicalTrials.gov NCT00097292.

Copyright © 2017 Endocrine Society

Figures

Figure 1.
Figure 1.
Influence of ceBMI on progression to type 1 diabetes in adults is evident in age and sex subsets. Proportion type 1 diabetes free among (A) male and (B) female adult participants of the PTP cohort comparing age (≥35 years vs 2 vs <5 kg/m2, respectively, corresponding sustained BMI on average above vs below the obesity cut-point) subsets defined by recursive partitioning.

Source: PubMed

3
Suscribir